18 articles · page 1 of 2 · showing 1 to 12
Precision Neuroscience raises $250 million to advance its brain-computer interface technology, focusing on implantable neural devices that translate brain signals into digital commands.
AI-powered blood tests from companies like GRAIL, Guardant Health and Freenome are exploring new ways to detect cancer signals through molecular data.
AI is being used to match patients, select trial sites, analyse clinical data and support drug development as AI-designed candidates reach later-stage trials.
Anthropic says its AI model Claude helped identify a new enzyme system with properties similar to CRISPR through biological research.
AI biotech startup Enveda raises $311 million to advance nature-derived drug candidates into human clinical trials.
Anthropic confirms it operates a wet biology lab in the Bay Area where AI models support physical experiments focused on fundamental biology research.
Evvy raised $40 million in Series B funding to expand vaginal microbiome testing, women’s health research, fertility work and personalised care.
Outer Biosciences uses living human skin and machine learning to discover new cosmetic ingredients, keeping tissue viable for up to four weeks in the lab.
Moderna and Merck say their personalised mRNA cancer therapy met key Phase 3 goals in melanoma, reducing the risk of recurrence and distant metastasis.
Vivodyne opened a human biological data centre with 12 robotic HIVE labs designed to generate large-scale human tissue data for AI drug discovery research.
Science Corporation has secured European regulatory approval for its PRIMA vision-restoring implant, bringing the brain-computer interface technology closer to commercial use for patients…
Dimension Capital has raised an $800 million third fund, expanding its investment strategy focused on AI, biotechnology and deep technology startups.
Written by the reporters who cover each beat. Unsubscribe in one click.
